Vascular Diseases Clinical Trial
Official title:
Comparison of a Short Compression Hosiery (Stocking Without a Foot) With Standard Compression Stockings After Radiofrequency Ablation of Great Saphenous Vein With Phlebectomy: a Multicenter Randomized Controlled Non-inferiority Trial
A prospective comparative randomized multicentre non-inferiority trial. The purpose of this study is to compares of a short compression hosiery (stocking without a foot, compression class 2) with standard compression class 2 stockings for 7 days after the endovascular radiofrequency ablation of great saphenous vein with phlebectomy varicose tributaries.
It is common practice to use compression hosiery in the postoperative period to reduce pain,
swelling, ecchymosis and hematoms. Long-term compression therapy is associated with a number
of inconveniences, which leads to a decrease in compliance and violation of the patient's
appointed treatment schedule. The use of short compression stoking can improve the compliance
to applying of compression in a round-the-clock mode while maintaining the effectiveness of
therapy.
The aim of the study The purpose of this study is to compare a short compression hosiery
(stocking without a foot, compression class 2) with standard compression class 2 stockings
for 7 days after the endovascular radiofrequency ablation of great saphenous vein with
phlebectomy varicose tributaries.
Materials and methods A Multicenter Randomized Controlled Non-inferiority Trial. The study
compares the effectiveness of a short compression hosiery (stocking without a foot,
compression class 2) with standard compression class 2 stockings for 7 days after the
endovascular radiofrequency ablation of great saphenous vein with phlebectomy varicose
tributaries.
The study includes patients who are scheduled for the radiofrequency ablation of the great
saphenous vein and phlebectomy varicose tributaries (CEAP classification classes C2-C4).
Endpoints in the study: the main outcome (primary endpoint) is the quality of life according
to CIVIQ questionnaire on the 30th day after the intervention. Additional outcomes (secondary
endpoints): comfort of using short compression stocking with the visual analog scale (VAS),
pain level with the visual analogue scale (VAS), foot swelling. Registration of results for
additional outcomes is conducted on days 1, 7, 14 and 30.
The calculation of the sample size was made using the online calculator "Compare 2 Means: 2
Sample Non Inferiority or Superiority" (https://goo.gl/8ND8CQ). The sample size was
calculated taking into account the average values for the CIVIQ quality of life questionnaire
on day 30 after the endovascular treatment obtained by reviewing the literature. Selected
parameters: first-order error (α) 2.5%; power 80%; boundaries of "non-inferiority limit" 5;
the expected difference between the study groups of 0. Taking into account the possible
dropout of patients from the study, the size of the groups is increased by 10%. The estimated
sample size is 164 participants. Randomization of patients into groups is carried out with
the help of the system of randomization of the site "Register of methods for treatment of
chronic disease."
Statistical analysis. It is planned to conduct ITT - analysis (intentio-to-treat). For
comparison, the primary and secondary outcomes will use nonparametric statistics
(Mann-Whitney U-test).
Discussion The main purpose of this study is to evaluate the effectiveness of a new type of
compression hosiery of a Russian manufacturer. The main hypotheses of the study: 1) it is
expected that the absence of a "foot" in hosiery will increase the comfort of its use and
increase the compliance of patients to the prescribed compression regime after intervention;
2) it is assumed that the lack of compression in the foot area will not lead to the
development of its swelling and a decrease in the comfort of wearing compression hosiery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05971407 -
The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Completed |
NCT01684826 -
X-ray Dose Reduction Study for Cardiac Angiography and Intervention
|
N/A | |
Completed |
NCT01417910 -
Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients
|
N/A | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Unknown status |
NCT01748383 -
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
|
Phase 2 | |
Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
Recruiting |
NCT03732612 -
Inflammation in Vascular Disease
|
||
Completed |
NCT00000614 -
Prevention of Recurrent Venous Thromboembolism (PREVENT)
|
Phase 3 | |
Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
Completed |
NCT00000530 -
Raynaud's Treatment Study (RTS)
|
Phase 3 | |
Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
Completed |
NCT00000474 -
Prevention and Treatment of Hypertension Study (PATHS)
|
Phase 3 | |
Completed |
NCT00000528 -
Trials of Hypertension Prevention (TOHP)
|
Phase 3 | |
Completed |
NCT00000509 -
Potassium and Sodium to Control Blood Pressure in Hypertensives
|
Phase 3 | |
Completed |
NCT00000501 -
Hypertension Prevention Trial (HPT) Feasibility Study
|
Phase 2 | |
Completed |
NCT00000499 -
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
|
Phase 2 |